BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 38177287)

  • 1. The roles of long noncoding RNA NEAT1 in cardiovascular diseases.
    Jiang X; Zhang M
    Hypertens Res; 2024 Mar; 47(3):735-746. PubMed ID: 38177287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA/circular noncoding RNA-miRNA-mRNA axes in cardiovascular diseases.
    Li M; Duan L; Li Y; Liu B
    Life Sci; 2019 Sep; 233():116440. PubMed ID: 31047893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of long noncoding RNA NEAT1 attenuates hypoxia-induced cardiomyocytes injury by targeting miR-378a-3p.
    Zhao J; Chen F; Ma W; Zhang P
    Gene; 2020 Mar; 731():144324. PubMed ID: 31904498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA nuclear-enriched abundant transcript 1 inhibition blunts myocardial ischemia reperfusion injury via autophagic flux arrest and apoptosis in streptozotocin-induced diabetic rats.
    Ma M; Hui J; Zhang QY; Zhu Y; He Y; Liu XJ
    Atherosclerosis; 2018 Oct; 277():113-122. PubMed ID: 30205319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients.
    Gast M; Rauch BH; Haghikia A; Nakagawa S; Haas J; Stroux A; Schmidt D; Schumann P; Weiss S; Jensen L; Kratzer A; Kraenkel N; Müller C; Börnigen D; Hirose T; Blankenberg S; Escher F; Kühl AA; Kuss AW; Meder B; Landmesser U; Zeller T; Poller W
    Cardiovasc Res; 2019 Nov; 115(13):1886-1906. PubMed ID: 30924864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Long Non-Coding RNAs in Cardiovascular Diseases.
    Le LTT; Nhu CXT
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanisms and therapeutic potential of long noncoding RNA NEAT1 in fibrosis.
    Jiang X
    Clin Exp Med; 2023 Nov; 23(7):3339-3347. PubMed ID: 37740135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia-Reperfusion Injury.
    Marinescu MC; Lazar AL; Marta MM; Cozma A; Catana CS
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases.
    Cao M; Luo H; Li D; Wang S; Xuan L; Sun L
    Int J Cardiol; 2022 Apr; 353():109-117. PubMed ID: 35143876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the silence: A comprehensive exploration of long non-coding RNAs as genetic whispers and their essential regulatory functions in cardiovascular disorders.
    Xiong Y; Alnoud MAH; Ali H; Ali I; Ahmad S; Khan MU; Hassan SSU; Majid M; Khan MS; Ahmad RUS; Khan SU; Khan KA; White A
    Curr Probl Cardiol; 2024 Mar; 49(3):102390. PubMed ID: 38232927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury.
    Ong SB; Katwadi K; Kwek XY; Ismail NI; Chinda K; Ong SG; Hausenloy DJ
    Expert Opin Ther Targets; 2018 Mar; 22(3):247-261. PubMed ID: 29417868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding NEAT1 weakens the protective role of sevoflurane on myocardial ischemia/reperfusion injury by mediating the microRNA-140/RhoA axis.
    Rui PF; Wang JH; Xu J
    J Biol Regul Homeost Agents; 2021; 35(3):933-944. PubMed ID: 34060267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging roles of long noncoding RNAs in common cardiovascular diseases.
    Jiang X; Ning Q
    Hypertens Res; 2015 Jun; 38(6):375-9. PubMed ID: 25762413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of long noncoding RNAs in myocardial pathophysiology.
    Chen C; Tang Y; Sun H; Lin X; Jiang B
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31694052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNAs in age-related cardiovascular diseases.
    Jusic A; Thomas PB; Wettinger SB; Dogan S; Farrugia R; Gaetano C; Tuna BG; Pinet F; Robinson EL; Tual-Chalot S; Stellos K; Devaux Y;
    Ageing Res Rev; 2022 May; 77():101610. PubMed ID: 35338919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.
    Zhang C; Niu K; Lian P; Hu Y; Shuai Z; Gao S; Ge S; Xu T; Xiao Q; Chen Z
    Hypertension; 2021 Jul; 78(1):16-29. PubMed ID: 34058852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs modulate autophagy in myocardial ischemia-reperfusion injury: a systematic review.
    Huang F; Mai J; Chen J; He Y; Chen X
    J Cardiothorac Surg; 2021 May; 16(1):140. PubMed ID: 34022925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-coding RNA and their potential role in cardiovascular diseases.
    Samra M; Srivastava K
    Gene; 2023 Jan; 851():147011. PubMed ID: 36326502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of the NEAT1/miR-22-3p/Ltb4r1 signaling pathway in mice with myocardial injury following acute myocardial infarction.
    Wang L; Wang L; Wang Q
    Aging (Albany NY); 2021 Jun; 13(11):15307-15319. PubMed ID: 34081624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.